Skip to main content

Media

Latest News

Press Release
July 14, 2021
“Thanks to the strong leadership of President Biden and Congressional Democrats, two million more Americans have now enrolled in the Affordable Care Act’s life-saving, affordable health coverage, including many who have lost coverage through no fault of their own during this pandemic."
Press Release
July 14, 2021
This week, proudly, Democrats have continued our progress to Build Back Better, with the Senate Budget Committee yesterday announcing its strong topline budget agreement.
Press Release
July 14, 2021

San Francisco – Speaker Nancy Pelosi issued this statement after the en banc D.C. Circuit granted House Democrats' motion to vacate a wrongly-decided ruling relating to enforcement of House subpoena power. This ruling reinstates the prior D.C. Circuit en banc opinion holding that the House has standing to sue to enforce its subpoenas:

Blog Post
July 13, 2021

From the Speaker's Press Office:

Americans are dying preventable deaths from COVID-19, but Kevin McCarthy's House GOP is busy fanning the flames of conspiracy theories about lifesaving vaccines.

Blog Post
July 11, 2021
While most Americans spend their Sundays relaxing with family, singing at church, or grilling burgers, former President Trump took to Fox News to join House Republicans in insulting the Capitol Police and praising the insurrectionists who attacked them on January 6th.
Blog Post
July 9, 2021

From the Speaker's Press Office:

Every single House Republican voted to defund the Capitol Police.

Blog Post
July 9, 2021

From the Speaker's Press Office:

Minority Leader McCarthy came down harder on Congresswoman Liz Cheney than he did on a member of his conference being investigated for sex trafficking minors.

Press Release
July 8, 2021
Speaker Nancy Pelosi joined Chairwoman Carolyn Maloney, Congressman Peter Welch and advocates to release a new Oversight and Reform Committee staff report analyzing the financial data of fourteen of the largest drug companies in the world to evaluate the amount they spend to enrich investors and executives, the amount they invest to research and develop new treatments and the potential impact of direct Medicare price negotiations.